137 related articles for article (PubMed ID: 27113362)
1. Impact of tailored patient education on adherence of patients with chronic myeloid leukaemia to tyrosine kinase inhibitors: a randomized multicentre intervention study.
Kekäle M; Söderlund T; Koskenvesa P; Talvensaari K; Airaksinen M
J Adv Nurs; 2016 Sep; 72(9):2196-206. PubMed ID: 27113362
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
Support Care Cancer; 2020 Jul; 28(7):3237-3247. PubMed ID: 31734798
[TBL] [Abstract][Full Text] [Related]
3. Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors.
Rychter A; Jerzmanowski P; Hołub A; Specht-Szwoch Z; Kalinowska V; Tęgowska U; Seferyńska I; Kołkowska-Leśniak A; Lech-Marańda E; Góra-Tybor J
Med Oncol; 2017 Jun; 34(6):104. PubMed ID: 28444623
[TBL] [Abstract][Full Text] [Related]
4. Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.
Leader A; Benyamini N; Gafter-Gvili A; Dreyer J; Calvarysky B; Amitai A; Yarchovsky-Dolberg O; Sharf G; Tousset E; Caspi O; Ellis M; Levi I; De Geest S; Raanani P
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e449-e461. PubMed ID: 30030034
[TBL] [Abstract][Full Text] [Related]
5. Two-Way Clinical Messaging in a CML Specialty Pharmacy Service Model.
Sawicki C; Friend KE; Patel R; Polinski JM; Singh S
J Manag Care Spec Pharm; 2019 Nov; 25(11):1290-1296. PubMed ID: 31663460
[TBL] [Abstract][Full Text] [Related]
6. Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan.
Tsai YF; Huang WC; Cho SF; Hsiao HH; Liu YC; Lin SF; Liu TC; Chang CS
Medicine (Baltimore); 2018 Jun; 97(26):e11322. PubMed ID: 29953021
[TBL] [Abstract][Full Text] [Related]
7. Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital.
Lee PM; Chang CT; Yusoff ZM
Int J Clin Pharm; 2021 Feb; 43(1):46-54. PubMed ID: 32524510
[TBL] [Abstract][Full Text] [Related]
8. Experiences of living with chronic myeloid leukaemia and adhering to tyrosine kinase inhibitors: A thematic synthesis of qualitative studies.
Hewison A; Atkin K; McCaughan D; Roman E; Smith A; Smith G; Howell D
Eur J Oncol Nurs; 2020 Apr; 45():101730. PubMed ID: 32169687
[TBL] [Abstract][Full Text] [Related]
9. Impact of a text messaging pilot program on patient medication adherence.
Foreman KF; Stockl KM; Le LB; Fisk E; Shah SM; Lew HC; Solow BK; Curtis BS
Clin Ther; 2012 May; 34(5):1084-91. PubMed ID: 22554973
[TBL] [Abstract][Full Text] [Related]
10. Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort.
de Almeida MH; Pagnano KB; Vigorito AC; Lorand-Metze I; de Souza CA
Acta Haematol; 2013; 130(1):16-22. PubMed ID: 23363706
[TBL] [Abstract][Full Text] [Related]
11. Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner.
Cornelison M; Jabbour EJ; Welch MA
J Support Oncol; 2012; 10(1):14-24. PubMed ID: 22244674
[TBL] [Abstract][Full Text] [Related]
12. Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project.
Botti S; Gargiulo G; Bombaci F; Artioli G; Cosentino C; Pignatelli AC; Torino D; Lionetti MM; Samarani E; Cappucciati L; Bordiga P; Diodati A; Caffarri C; Rosini I; Pane F
Acta Biomed; 2017 Jul; 88(3S):5-12. PubMed ID: 28752827
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.
Geissler J; Sharf G; Bombaci F; Daban M; De Jong J; Gavin T; Pelouchova J; Dziwinski E; Hasford J; Hoffmann VS
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1167-1176. PubMed ID: 28289895
[TBL] [Abstract][Full Text] [Related]
14. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis.
Thakkar J; Kurup R; Laba TL; Santo K; Thiagalingam A; Rodgers A; Woodward M; Redfern J; Chow CK
JAMA Intern Med; 2016 Mar; 176(3):340-9. PubMed ID: 26831740
[TBL] [Abstract][Full Text] [Related]
15. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study.
Kamal AK; Shaikh Q; Pasha O; Azam I; Islam M; Memon AA; Rehman H; Akram MA; Affan M; Nazir S; Aziz S; Jan M; Andani A; Muqeet A; Ahmed B; Khoja S
BMC Neurol; 2015 Oct; 15():212. PubMed ID: 26486857
[TBL] [Abstract][Full Text] [Related]
17. Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase.
Guérin A; Chen L; Dea K; Wu EQ; Goldberg SL
Curr Med Res Opin; 2014 Jul; 30(7):1345-52. PubMed ID: 24640967
[TBL] [Abstract][Full Text] [Related]
18. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring.
Armstrong AW; Watson AJ; Makredes M; Frangos JE; Kimball AB; Kvedar JC
Arch Dermatol; 2009 Nov; 145(11):1230-6. PubMed ID: 19917951
[TBL] [Abstract][Full Text] [Related]
19. Electronic messaging support service programs improve adherence to lipid-lowering therapy among outpatients with coronary artery disease: an exploratory randomised control study.
Fang R; Li X
J Clin Nurs; 2016 Mar; 25(5-6):664-71. PubMed ID: 26522838
[TBL] [Abstract][Full Text] [Related]
20. Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
Santoleri F; Lasala R; Ranucci E; La Barba G; Di Lorenzo R; Vetrò A; Di Bartolomeo P; Costantini A
Acta Haematol; 2016; 136(1):45-51. PubMed ID: 27160310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
